Background, objectives and methods: For severer ischemic cardiomyopathy (ICM), the ventricular assist device (VAD) can be applied as well as conventional surgery such as coronary artery bypass grafting (CABG), mitral valve procedures and surgical ventricular restoration (SVR). ICM patients with left ventricular ejection fraction less than 30 % who underwent surgery including SVR and VAD implantation were selected, and their contemporary results of surgical treatment were retrospectively analyzed. Results: In-hospital mortality of CABG group, SVR group, and VAD group were 10 %, 10.5 % and 75 %, respectively. Preoperative renal dysfunction, mitral regurgitation≧3, and concomitant mitral valve procedure were identified as risk factors for in-hospital mortality in this patients cohort. Kaplan-Meier analysis revealed that overall survival rates at 1 year and 5 year were 85 %, 80 % in CABG group; 89.7 %, 89.7 % in SVR group; 50 %, 0 % in LVAD group, respectively (p=0.028). Conclusions: Although long-term results after surgical treatment of ICM patients were acceptable, operative mortality was still high for these cohorts, and further improvement has been required.
View full abstract